Sort
59,101 grants matching “hypertension”
GENHAT-GENETICS OF HYPERTENSION ASSOCIATED TREATMENTS
$999,971University Of Alabama At Birmingham · R01 · FY2003 · HL
First-In-Human Feasibility Trial of Break Wave - The Office-Based Lithotripsy Solution
$999,958Oren Levy · Sonomotion, Inc. · R44 · FY2019 · DK
An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension
$999,898Lawrence S. Zisman · Pulmokine, Inc. · R44 · FY2015 · HL
A Bullet Proof vascular graft to prevent dialysis access cannulation injury
$999,841Joseph Knight · Innavasc Medical, Inc. · R44 · FY2020 · DK
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
$999,799Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2023 · HL
Lipid Receptor GPR31 as a Target for Anti-Thrombotic and Stroke Therapy
$999,799Athan Kuliopulos · Oasis Pharmaceuticals · R42 · FY2024 · HL
An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension
$999,751Lawrence S. Zisman · Pulmokine, Inc. · R44 · FY2017 · HL
Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass
$999,580Jonathan A Winger · Omniox, Inc. · R44 · FY2023 · HD
Down Syndrome Connect Registry
$999,558Joaquin M. Espinosa · University Of Colorado Denver · OT2 · FY2025 · HD
An inhaled PDGF receptor inhibitor for the treatment of pulmonary arterial hypertension
$999,482Lawrence S. Zisman · Pulmokine, Inc. · R44 · FY2016 · HL
Iridium-electrode inhaled Nitric Oxide generator for treatment of hypoxic respiratory failure in neonates
$999,466Philip E Silkoff · Third Pole, Inc. · R44 · FY2019 · HL
Building Sustainable Community-Linked Infrastructure: The FCHL Collaborative
$999,346Thomas A Arcury · Wake Forest University Health Sciences · RC4 · FY2010 · HL
Neuropeptides and Carboxypeptidase E/ Neurotrophic Factor-1 in Neural and Cognitive Functions
$999,238Yoke Peng Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD
A Bullet Proof vascular graft to prevent dialysis access cannulation injury
$999,169Joseph Knight · Innavasc Medical, Inc. · R44 · FY2021 · DK
AWI-Gen Phase 2: Genomic and environmental risk factors for cardiometabolic disease in Africans
$999,112Michele Michele Ramsay · Wits Health Consortium (Pty), Ltd · U54 · FY2019 · HG
Mechanisms of Drug Disposition During Pregnancy
$998,989Jashvant D Unadkat · University Of Washington · P01 · FY2017 · DA
COOPERATIVE MULTICENTER MFM UNITS NETWORK
$998,832Women And Infants Hospital-Rhode Island · U10 · FY2002 · HD
Hepatocyte xenografts for treatment of acute liver failure
$998,829Ira J. Fox · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AI
Portable electrical nitric oxide generator for treatment of pulmonary hypertension accompanying interstitial lung disease
$998,712Greg Hall · Third Pole, Inc. · R44 · FY2021 · TR
Center to Improve Clinical Diagnosis
$998,687Goutham Rao · University Hospitals Of Cleveland · R18 · FY2022 · HS
A Genome-Wide Association Study in Essential Hypertension (FEHGAS2)
$998,644Aravinda Chakravarti · Johns Hopkins University · R01 · FY2013 · HL
Epidemiology of Sleep-Disordered Breathing in Adults
$998,610Terry B Young · University Of Wisconsin-Madison · R01 · FY2006 · HL
Shake, Rattle and Roll
$998,360Mai N Nguyen-Huynh · Kaiser Foundation Research Institute · U54 · FY2014 · NS
Chronic Kidney Disease in Children (CKiD III)
$998,262Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2016 · DK
Subclinical Atrial Fibrillation and Supraventricular Ectopy in the Jackson Heart Study
$998,176James S Floyd · University Of Washington · R01 · FY2020 · HL